POAHA
Progress 2020-1 Trust
๐ฆ๐บ ASX
๐ Overview
๐ Performance
๐ต Cost
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
N/A
Annual Growth
5 years average annual growth
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
0
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Class A Flot Note Mat 24-Jun-2051 Min Cons $5Ht Nc
๐ Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in POAHA
0
๐ Total Capital Earnings
N/A
๐ Average investment frequency
N/A
๐ต Average investment amount
N/A
โฐ Last time a customer invested in POAHA
N/A
POAHA investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
35 - 90
๐ Legal gender of investors
Female
Male
Pearlers who invest in POAHA also invest in...
Want more shares? Try these...
Polynovo Ltd. engages in the development of medical devices, utilizing the patented polymer technology NovoSorb. The company is headquartered in Melbourne, Victoria and currently employs 237 full-time employees. Its solutions include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a synthetic, biodegradable and biocompatible device designed to facilitate the dermis to grow within a patented polyurethane matrix when lost through extensive surgery, trauma or burn. NovoSorb BTM is indicated for use in the management of wounds, including partial and full thickness wounds, pressure ulcers, venous and diabetic ulcers, chronic and vascular ulcers, surgical wounds, trauma wounds and draining wounds. Its development program covers breast sling, hernia, and orthopedic applications. NovoSorb MTX is available in a range of sizes to address acute and chronic dermal wounds and is comprised of a 2mm biodegradable foam with no sealing membrane.
๐ Performance (5Yr p.a)
-3.81%
๐ Share price
$1.98 AUD
๐ฉบ HEALTH CARE
Purifloh Ltd. engages in the provision of chemical free indoor air purification, water sanitation and surface sterilization solutions. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2010-12-30. The Companyโs principal activities include the development of its Free Radical Generator (FRG) technology for a range of applications, such as indoor air purification, water sanitation and medical sterilization. The FRG technology produces a range of reactive oxygen species (ROS) that include the hydroxyl radical, superoxide radical, oxygen radical and the ozone molecule. Its devices are engineered to control the plasma characteristics and selectively increase or decrease the production of specific oxygen and hydroxyl-based free radicals to target specific contaminants effectively without leaving toxic levels of any by-products. Its subsidiary is PuriflOH USA Incorporated.
๐ Performance (5Yr p.a)
-19.23%
๐ Share price
$0.22 AUD
๐ UTILITIES